ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39 | -36.1% | 12,171 | 0.0% | 0.00% | – |
Q2 2023 | $61 | +41.9% | 12,171 | +37.9% | 0.00% | – |
Q1 2023 | $43 | -2.3% | 8,827 | +26.1% | 0.00% | – |
Q4 2022 | $44 | -99.9% | 7,001 | +12.5% | 0.00% | – |
Q3 2022 | $67,000 | +1.5% | 6,224 | +8.4% | 0.00% | – |
Q2 2022 | $66,000 | +32.0% | 5,740 | +9.6% | 0.00% | – |
Q1 2022 | $50,000 | -30.6% | 5,237 | +9.4% | 0.00% | – |
Q4 2021 | $72,000 | -35.7% | 4,787 | +10.1% | 0.00% | – |
Q3 2021 | $112,000 | -0.9% | 4,348 | 0.0% | 0.00% | – |
Q2 2021 | $113,000 | -28.9% | 4,348 | -4.4% | 0.00% | – |
Q1 2021 | $159,000 | +74.7% | 4,549 | +25.9% | 0.00% | – |
Q4 2020 | $91,000 | -33.1% | 3,614 | 0.0% | 0.00% | – |
Q3 2020 | $136,000 | -11.7% | 3,614 | 0.0% | 0.00% | – |
Q2 2020 | $154,000 | +381.2% | 3,614 | +122.1% | 0.00% | – |
Q1 2020 | $32,000 | -23.8% | 1,627 | 0.0% | 0.00% | – |
Q4 2019 | $42,000 | -48.8% | 1,627 | -47.0% | 0.00% | – |
Q2 2019 | $82,000 | – | 3,067 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |